Daniel R. Passeri
2022 - Cue Biopharma
In 2022, Daniel R. Passeri earned a total compensation of $1.4M as Chief Executive Officer at Cue Biopharma.
Compensation breakdown
| Bonus | $234,637 |
|---|---|
| Option Awards | $388,130 |
| Salary | $747,507 |
| Other | $3,576 |
| Total | $1,373,850 |
Passeri received $747.5K in salary, accounting for 54% of the total pay in 2022.
Passeri also received $234.6K in bonus, $388.1K in option awards and $3.6K in other compensation.
Rankings
In 2022, Daniel R. Passeri's compensation ranked 2,413th out of 5,717 executives tracked by ExecPay. In other words, Passeri earned more than 57.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,413 out of 5,717 | 58th |
Division Manufacturing | 1,320 out of 3,111 | 58th |
Major group Chemicals And Allied Products | 590 out of 1,410 | 58th |
Industry group Drugs | 544 out of 1,311 | 59th |
Industry Pharmaceutical Preparations | 392 out of 957 | 59th |
Source: SEC filing on April 26, 2024.
Passeri's colleagues
We found two more compensation records of executives who worked with Daniel R. Passeri at Cue Biopharma in 2022.